ADAP
Baillie Gifford & Co’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,819,095
| Closed | -$6.37M | – | 267 |
|
|
2024
Q4 | $6.37M | Sell |
11,819,095
-4,956,765
| -30% | -$2.67M | ﹤0.01% | 223 |
|
|
2024
Q3 | $15.9M | Buy |
16,775,860
+1,626,657
| +11% | +$1.55M | 0.01% | 191 |
|
|
2024
Q2 | $14.8M | Sell |
15,149,203
-722,672
| -5% | -$705K | 0.01% | 193 |
|
|
2024
Q1 | $25.1M | Sell |
15,871,875
-40,265
| -0.3% | -$63.6K | 0.02% | 180 |
|
|
2023
Q4 | $12.6M | Sell |
15,912,140
-1,235,269
| -7% | -$980K | 0.01% | 208 |
|
|
2023
Q3 | $13.4M | Sell |
17,147,409
-28,726
| -0.2% | -$22.4K | 0.01% | 204 |
|
|
2023
Q2 | $15.9M | Buy |
17,176,135
+64,133
| +0.4% | +$59.3K | 0.01% | 194 |
|
|
2023
Q1 | $18.7M | Sell |
17,112,002
-57,937
| -0.3% | -$63.2K | 0.02% | 187 |
|
|
2022
Q4 | $25.1M | Buy |
17,169,939
+2,505,003
| +17% | +$3.66M | 0.03% | 180 |
|
|
2022
Q3 | $15.8M | Sell |
14,664,936
-656,410
| -4% | -$706K | 0.02% | 197 |
|
|
2022
Q2 | $26M | Sell |
15,321,346
-59,192
| -0.4% | -$101K | 0.03% | 182 |
|
|
2022
Q1 | $31.7M | Buy |
15,380,538
+1,624,186
| +12% | +$3.35M | 0.02% | 191 |
|
|
2021
Q4 | $51.6M | Buy |
13,756,352
+931,372
| +7% | +$3.49M | 0.03% | 184 |
|
|
2021
Q3 | $66.3M | Buy |
12,824,980
+1,128,061
| +10% | +$5.83M | 0.03% | 165 |
|
|
2021
Q2 | $49.8M | Buy |
11,696,919
+229,402
| +2% | +$977K | 0.02% | 192 |
|
|
2021
Q1 | $60.9M | Buy |
11,467,517
+1,109,737
| +11% | +$5.89M | 0.03% | 164 |
|
|
2020
Q4 | $55.8M | Buy |
10,357,780
+3,279,717
| +46% | +$17.7M | 0.03% | 160 |
|
|
2020
Q3 | $56.5M | Buy |
7,078,063
+1,788,394
| +34% | +$14.3M | 0.04% | 146 |
|
|
2020
Q2 | $53M | Buy |
5,289,669
+935,646
| +21% | +$9.37M | 0.04% | 133 |
|
|
2020
Q1 | $11.8M | Buy |
4,354,023
+66,478
| +2% | +$181K | 0.01% | 163 |
|
|
2019
Q4 | $5.15M | Buy |
4,287,545
+122,738
| +3% | +$147K | 0.01% | 188 |
|
|
2019
Q3 | $6.29M | Buy |
4,164,807
+20,967
| +0.5% | +$31.7K | 0.01% | 186 |
|
|
2019
Q2 | $16.7M | Buy |
4,143,840
+304,650
| +8% | +$1.22M | 0.02% | 166 |
|
|
2019
Q1 | $16.5M | Buy |
3,839,190
+139,669
| +4% | +$601K | 0.02% | 169 |
|
|
2018
Q4 | $21.3M | Buy |
3,699,521
+281,894
| +8% | +$1.62M | 0.03% | 154 |
|
|
2018
Q3 | $46.3M | Buy |
3,417,627
+384,366
| +13% | +$5.21M | 0.05% | 121 |
|
|
2018
Q2 | $36M | Buy |
3,033,261
+467,852
| +18% | +$5.55M | 0.04% | 124 |
|
|
2018
Q1 | $28.8M | Buy |
2,565,409
+644,816
| +34% | +$7.24M | 0.03% | 125 |
|
|
2017
Q4 | $12.8M | Buy |
1,920,593
+541,289
| +39% | +$3.62M | 0.02% | 155 |
|
|
2017
Q3 | $11.3M | Buy |
1,379,304
+55,996
| +4% | +$459K | 0.01% | 156 |
|
|
2017
Q2 | $5.94M | Buy |
1,323,308
+402,324
| +44% | +$1.81M | 0.01% | 178 |
|
|
2017
Q1 | $5.08M | Hold |
920,984
| – | – | 0.01% | 171 |
|
|
2016
Q4 | $3.73M | Hold |
920,984
| – | – | 0.01% | 183 |
|
|
2016
Q3 | $6.49M | Buy |
920,984
+491,284
| +114% | +$3.46M | 0.01% | 172 |
|
|
2016
Q2 | $3.5M | Hold |
429,700
| – | – | 0.01% | 180 |
|
|
2016
Q1 | $3.49M | Buy |
+429,700
| New | +$3.49M | 0.01% | 181 |
|